Khaitan & Co advised Nirma Limited on the deal. Nirma Limited completed the acquisition of a majority stake of 75% in Glenmark Life Sciences Limited from Glenmark...
Nirma Limited’s Acquisition of a Majority Stake in Glenmark Life Sciences
Givfunds Social Ventures’ FCA Registration
Ashurst advises social enterprise Givfunds on FCA registration. Givfunds Social Ventures obtained the registration with the Financial Conduct Authority (FCA). Givfunds, a social enterprise, works to bridge...
ACRE’s Acquisition of Debt from KKR
Khaitan & Co acted as the legal adviser to Asset Care & Reconstruction Enterprise Limited (ACRE). Asset Care & Reconstruction Enterprise Limited (ACRE), which was backed...
PepGen’s $108 Million Initial Public Offering
Latham & Watkins represented the underwriters in the IPO while Goodwin advised PepGen. PepGen, Inc., a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with...
Amylyx Pharmaceuticals’ $190 Million IPO
Wilmer Cutler Pickering Hale and Dorr advised the underwriters on the deal while Goodwin Procter represented Amylyx Pharmaceuticals. Amylyx Pharmaceuticals, Inc. (“Amylyx”), a clinical-stage pharmaceutical company...
Korro Bio’s $116 Million Series B Financing
Goodwin advised Korro Bio on the deal. Korro Bio, Inc. announced its $116 million Series B financing. Korro is an RNA editing company focused on discovery...